These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 15191384

  • 1. Potential risk factors for infection with Candida spp. in critically ill patients.
    Peres-Bota D, Rodriguez-Villalobos H, Dimopoulos G, Melot C, Vincent JL.
    Clin Microbiol Infect; 2004 Jun; 10(6):550-5. PubMed ID: 15191384
    [Abstract] [Full Text] [Related]

  • 2. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M, Sorrell TC.
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [Abstract] [Full Text] [Related]

  • 3. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V, Barnes AJ.
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF, Lazarus DR, Sherner JH, Jackson WL, Morrel M, Fraser VJ, Kollef MH.
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality].
    Acar A, Oncül O, Küçükardali Y, Ozyurt M, Haznedaroğlu T, Cavuşlu S.
    Mikrobiyol Bul; 2008 Jul; 42(3):451-61. PubMed ID: 18822889
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
    Davis SL, Vazquez JA, McKinnon PS.
    Ann Pharmacother; 2007 Apr; 41(4):568-73. PubMed ID: 17374623
    [Abstract] [Full Text] [Related]

  • 11. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
    Husain S, Tollemar J, Dominguez EA, Baumgarten K, Humar A, Paterson DL, Wagener MM, Kusne S, Singh N.
    Transplantation; 2003 Jun 27; 75(12):2023-9. PubMed ID: 12829905
    [Abstract] [Full Text] [Related]

  • 12. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
    Bassetti M, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M, Rebesco B, Bobbio Pallavicini F, Icardi G, Viscoli C.
    J Antimicrob Chemother; 2009 Sep 27; 64(3):625-9. PubMed ID: 19622536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk Factors for Candida tropicalis fungemia in patients with cancer.
    Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP, Raad II.
    Clin Infect Dis; 2001 Nov 15; 33(10):1676-81. PubMed ID: 11568858
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.
    Nace HL, Horn D, Neofytos D.
    Diagn Microbiol Infect Dis; 2009 Jul 15; 64(3):289-94. PubMed ID: 19376670
    [Abstract] [Full Text] [Related]

  • 16. Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data.
    Samonis G, Kofteridis DP, Saloustros E, Giannopoulou KP, Ntziora F, Christidou A, Maraki S, Falagas ME.
    Scand J Infect Dis; 2008 Jul 15; 40(5):414-9. PubMed ID: 18418802
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of multilocus sequence typing for the investigation of colonisation by Candida albicans in intensive care unit patients.
    Cliff PR, Sandoe JA, Heritage J, Barton RC.
    J Hosp Infect; 2008 May 15; 69(1):24-32. PubMed ID: 18396349
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E, Erturan Z, Susever S, Yegenoglu Y.
    APMIS; 2005 Apr 15; 113(4):278-83. PubMed ID: 15865609
    [Abstract] [Full Text] [Related]

  • 20. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
    Safdar A, Bannister TW, Safdar Z.
    Int J Infect Dis; 2004 May 15; 8(3):180-6. PubMed ID: 15109594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.